Jump to content
Powered by
  • Industry report The healthcare industry – the innovation driver of the 21st century: opportunities and challenges

    BIOPRO Baden-Württemberg’s new industry report entitled "The Healthcare Industry 2018: Facts and Figures for Baden-Württemberg" has just been published in both German and English.

  • Contact Stay in touch

    Would you like continue receiving e-mail notifications about our activities, up-to-date information, events, opportunities for cooperation and general industry information? Register here to stay informed about current issues.

  • Dossier Immunology – at the forefront of medical progress

    Immunological approaches are central to everything – learn more!

  • AI & Pharma AI in the Pharmaceutical Industry

    BIOPRO Baden-Württemberg is organising a two-day event on "Application Potential of Artificial Intelligence in the Pharmaceutical Industry". Save the dates and see you on April 22 and May 6, 2021!

AI application potential & Matchmaking


BIOPRO Baden-Württemberg together with Fraunhofer Institute for Manufacturing Engineering and Automation IPA are organising a two-day event on the topic "Application Potential of Artificial Intelligence in the Pharmaceutical Industry". The event kick-off takes place on 22 April 2021 and is entitled "AI in use in the pharmaceutical industry – day 1". On 6 May 2021, the event continues with "Meet & Match: AI in the pharmaceutical industry – day 2" which is dedicated to networking and matchmaking.

Networking Event

Registration deadline:

BIOPRO Baden-Württemberg GmbH and BioValley France organise their 19th joint Meet & Match event taking place on the 1st of July, 2021. It will be hosted as an online event offering exciting presentations, matchmaking pitches as well as networking sessions.

Latest news

  • Press release - 24/03/2021

    Immunotherapy using checkpoint inhibitors is effective in around a quarter of patients with liver cancer. However, to date, physicians have been unable to predict which patients would benefit from this type of treatment and which would not. Researchers from the German Cancer Research Center have now discovered that liver cancer caused by chronic inflammatory fatty liver disease does not respond to this treatment. On the contrary: in an…

  • Microfluidics in medical technology - 24/03/2021

    Karlsruhe-based company memetis shows that this is possible. Intelligent components for controlling fluids open up huge potential in the medical technology and biotechnology sectors - from vaccine development and cell line analysis to drug research and point-of-care solutions.

  • Press release - 23/03/2021

    CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today announced the publication of preclinical data demonstrating that their COVID-19 vaccine candidate, CVnCoV, protects against challenge infections with the SARS-CoV-2 Variant of Concern B.1.351 and a strain of the original SARS-CoV-2 B1 lineage (BavPat1) in a transgenic mouse model.

  • Press release - 19/03/2021

    A new method allows stem cells and cancer stem cells to be studied at the single cell level and the resulting cell clones to be traced directly. Studying thousands of individual cells in parallel, the researchers combined the analysis of the genomic cancer mutations with the associated expression profiles.

  • Article - 17/03/2021

    The analysis of pathogen biomarkers and biomarkers for the diagnosis of diseases can be crucial for health. However, the detection of pathogens and diseases depends on a sensitive and reliable method that delivers rapid results. Biosensors have such properties. Researchers at the Institute of Biochemistry and Technical Biochemistry (IBTB) at Stuttgart University have constructed an epigenetic circuit composed of plasmids that might make it…

Website address: https://www.gesundheitsindustrie-bw.de/en